SAMN47320889
External Id
dbGaP
INSDC center name
2025-03-12T12:11:20.500Z
INSDC first public
2025-04-25T10:03:59.893Z
INSDC last update
SRS24353451
INSDC secondary accession
live
INSDC status
Generic
NCBI submission model
Generic.1.0
NCBI submission package
SRS24353451
SRA accession
DNA
analyte type
NCI_AtezolizumabNeoantigen_UrothelialCancer
biospecimen repository
S28
biospecimen repository sample id
Blood
body site
phs003922
gap_accession
1
gap_consent_code
HMB
gap_consent_short_name
7559600
gap_sample_id
5602626
gap_subject_id
No
is tumor
Homo sapiens
http://purl.obolibrary.org/obo/NCBITaxon_9606
organism
male
sex
Clinical Trial
study design
Atezolizumab Plus Personalized Neoantigen Vaccination in Patients with Urothelial Cancer: a Phase 1 Trial
study name
S28
submitted sample id
GU011
submitted subject id
NCI_AtezolizumabNeoantigen_UrothelialCancer
submitter handle
Non-tumor DNA sample from Blood of a human male participant in the dbGaP study "Atezolizumab Plus Personalized Neoantigen Vaccination in Patients with Urothelial Cancer: a Phase 1 Trial"
title